Remnant cholesterol is associated with cardiovascular mortality

• Published in: Frontiers in cardiovascular medicine 2022-09, Vol.9, p.984711-984711
• Main Authors: Zhang, Kerui, Qi, Xiangyun, Zhu, Fuyu, Dong, Quanbin, Gou, Zhongshan, Wang, Fang, Xiao, Li, Li, Menghuan, Chen, Lianmin, Wang, Yifeng, Zhang, Haifeng, Sheng, Yanhui, Kong, Xiangqing
• Format: Article
• Language: English
• Subjects: Cardiovascular Medicine; cardiovascular mortality; correlational analysis; NHANES; remnant cholesterol; Sampson formula
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2022.984711

BackgroundGenetic, observational, and clinical intervention studies indicate that circulating levels of remnant cholesterol (RC) are associated with cardiovascular diseases. However, the predictive value of RC for cardiovascular mortality in the general population remains unclear. MethodsOur study population comprised 19,650 adults in the United States from the National Health and Nutrition Examination Survey (NHANES) (1999-2014). RC was calculated from non-high-density lipoprotein cholesterol (non-HDL-C) minus low-density lipoprotein cholesterol (LDL-C) determined by the Sampson formula. Multivariate Cox regression, restricted cubic spline analysis, and subgroup analysis were applied to explore the relationship of RC with cardiovascular mortality. ResultsThe mean age of the study cohort was 46.4 ± 19.2 years, and 48.7% of participants were male. During a median follow-up of 93 months, 382 (1.9%) cardiovascular deaths occurred. In a fully adjusted Cox regression model, log RC was significantly associated with cardiovascular mortality [hazard ratio (HR) 2.82; 95% confidence interval (CI) 1.17-6.81]. The restricted cubic spline curve indicated that log RC had a linear association with cardiovascular mortality (p for non-linearity = 0.899). People with higher LDL-C (≥130 mg/dL), higher RC [≥25.7/23.7 mg/dL in males/females corresponding to the LDL-C clinical cutoff point (130 mg/dL)] and abnormal HDL-C (